Benzinga - by Lisa Levin, Benzinga Editor.
Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20 per unit.
U Power shares dipped 54% to $0.7090 on Monday.
Here are some other stocks moving in today's mid-day session.
Gainers
- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares jumped 211.3% to $20.58 after the company announced the Phase 2 DAVIO 2 trial of EYP-1901 in wet AMD achieved all primary and secondary endpoints.
- Hawaiian Holdings, Inc. (NASDAQ: HA) shares climbed 187% to $14.03 after Alaska Air Group, Inc. (NYSE: ALK) announced plans to acquire the company in a deal worth $1.9 billion.
- Alterity Therapeutics Limited (NASDAQ: ATHE) shares climbed 156% to $4.25 after the company announced that ATHE434 new data in a Parkinson's disease primate model were presented at the Future of Parkinson's Disease Conference 2023.
- SilverSun Technologies, Inc. (NASDAQ: SSNT) gained 142.7% to $8.91 after the company announced Jacobs Private Equity II and minority co-investors will invest $1 billion in the company.
- Bit Brother Limited (NASDAQ: BETS) rose 86.3% to $0.0723 after surging 43% on Friday. Bit Brother said it purchased 3300 units of Antminer S19 miners, injecting powerful momentum into its Bitcoin mining operations.
- Lucy Scientific Discovery Inc. (NASDAQ: LSDI) shares jumped 72.2% to $0.3530.
- View, Inc. (NASDAQ: VIEW) gained 52.3% to $1.5701.
- Mawson Infrastructure Group, Inc. (NASDAQ: MIGI) rose 29.8% to $1.17.
- Marpai, Inc. (NASDAQ: MRAI) jumped 28.3% to $1.9250.
- CEL-SCI Corporation (NYSE: CVM) surged 25.6% to $2.6009. The UK'S National Institute for Health and Care Excellence selected CEL-SCI's Multikine as a potential new standard of care for head & neck cancer.
- Cutera, Inc. (NASDAQ: CUTR) gained 25.3% to $2.33.
- BIOLASE, Inc. (NASDAQ: BIOL) jumped 24.5% to $1.42.
- Marpai, Inc. (NASDAQ: MRAI) rose 24% to $1.86. Marpai confirmed it has filed an appeal to NASDAQ Delisting Letter.
- Beyond Meat, Inc. (NASDAQ: BYND) rose 23.6% to $9.36.
- Altimmune, Inc. (NASDAQ: ALT) climbed 23% to $4.3850.
- Ocular Therapeutix, Inc. (NASDAQ: OCUL) gained 23% to $3.2950.
- B. Riley Financial, Inc. (NASDAQ: RILY) rose 19.4% to $24.09. Bryant R. Riley reported sale of most of its stake in Arena Group to Arena.
- Terns Pharmaceuticals, Inc. (NASDAQ: TERN) gained 16.8% to $6.10.
- CleanSpark, Inc. (NASDAQ: CLSK) climbed 16.1% to $8.87amid a weekend increase in the price of Bitcoin.
- Newegg Commerce, Inc. (NASDAQ: NEGG) gained 15.5% to $2.08.
- Mercurity Fintech Holding Inc. (NYSE: MFH) jumped 15.4% to $1.12.
- Carvana Co. (NYSE: CVNA) gained 15.3% to $40.56 after JP Morgan upgraded the stock from Underweight to Neutral and raised its price target from $25 to $40.
- TeraWulf Inc. (NASDAQ: WULF) climbed 12.5% to $1.54 amid a weekend surge in the price of Bitcoin.
- Marathon Digital Holdings, Inc. (NASDAQ: MARA) gained 11.4% to $15.26 amid a weekend surge in the price of Bitcoin.
- Spotify Technology S.A. (NYSE: SPOT) gained 8.6% to $196.07. Spotify CEO Daniel Ek announced significant organizational changes, including reducing the company's headcount by approximately 17%.
- Soluna Holdings, Inc. (NASDAQ: SLNH) shares rose 7.7% to $3.6530 after gaining 9% on Friday.
- Science Applications International Corporation (NYSE: SAIC) gained 6.9% to $128.20 after the company reported third-quarter financial results and raised FY24 guidance above estimates.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- NexImmune, Inc. (NASDAQ: NEXI) fell 32.9% to $4.0619.
- Meta Materials Inc. (NASDAQ: MMAT) declined 30.4% to $0.0765. Meta Materials announced a $6.0 million registered direct offering.
- Clean Earth Acquisitions Corp. (NASDAQ: CLIN) fell 29.5% to $6.86.
- Volato, Inc. (NYSE: SOAR) fell 28% to $10.44. Volato announced an agreement with Fly Alliance, to offer expanded aircraft options to its Gulfstream G280, HondaJet and Volato Insider Program Max customers.
- Reborn Coffee, Inc. (NASDAQ: REBN) declined 24.4% to $0.5387.
- Garden Stage Limited (NASDAQ: GSIW) fell 20.6% to $8.10 after surging 155% on Friday. Garden Stage announced pricing of initial public offering.
- Dune Acquisition Corporation (NASDAQ: DUNE) fell 19% to $6.00.
- Minim, Inc. (NASDAQ: MINM) fell 18.4% to $2.6015.
- FOXO Technologies Inc. (NYSE: FOXO) shares fell 16.7% to $0.3404 after gaining over 22% on Friday. FOXO Technologies issued a business update on the planned commercial rollout of its new direct-to-consumer (DTC) app, the VITHAR™ AI Health Coach.
- NLS Pharmaceutics AG (NASDAQ: NLSP) dipped 16.6% to $0.5087 after jumping 39% on Friday. NLS Pharmaceutics launched an exclusive option agreement to develop and commercialize next generation dual orexin agonist platform of Aexon Labs.
- Virgin Galactic Holdings, Inc. (NYSE: SPCE) fell 16.2% to $1.96 following a report suggesting founder Richard Branson will not put any more money into the company.
- Vivos Therapeutics, Inc. (NASDAQ: VVOS) fell 15.4% to $16.83 after dipping 19% on Friday. Vivos Therapeutics recently received FDA 510(k) clearance for treating severe obstructive sleep apnea in adults using the Vivos' removable CARE oral appliances.
- Alaska Air Group, Inc. (NYSE: ALK) fell 15.1% to $33.72. Alaska Air Group announced plans to acquire Hawaiian Holdings in a deal worth $1.9 billion.
- Neumora Therapeutics, Inc. (NASDAQ: NMRA) declined 14.8% to $10.49.
- MINISO Group Holding Limited (NYSE: MNSO) dipped 11.6% to $21.42.
- Cuentas Inc. (NASDAQ: CUEN) shares fell 8.1% to $1.3973 after gaining over 18% on Friday.
- Sana Biotechnology, Inc. (NASDAQ: SANA) declined 8% to $3.72.
- Nokia Oyj (NYSE: NOK) fell 7.6% to $3.2250.
- Palantir Technologies Inc. (NYSE: PLTR) declined 7.2% to $18.82.
- Kanzhun Limited (NASDAQ: BZ) fell 7% to $14.85.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Now Read This: Bitcoin Tops $41,000; Terra Classic Emerges As Top Gainer
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.